EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Alveolar Epithelial Cell Proliferation and Lung Regeneration in the Lipopolysaccharide-Induced Acute Lung Injury Mouse Model

Raquel Fernandes, Catarina Barbosa-Matos iD, Caroline Borges-Pereira, Ana Luísa Rodrigues Toste de Carvalho iD, Sandra Costa iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25021279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Raquel Fernandes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal. Hauptthemen laut MEDLINE: Alveolar Epithelial Cells, Acute Lung Injury, Pyridines, Pyrimidines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Programa Operacional Temático Factores de Competitividade, Programa Operacional Potencial Humano (POPH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury that currently lacks effective clinical treatments. Evidence highlights the potential role of glycogen synthase kinase-3 (GSK-3) inhibition in mitigating severe inflammation. The inhibition of GSK-3α/β by CHIR99021 promoted fetal lung progenitor proliferation and maturation of alveolar epithelial cells (AECs). The precise impact of CHIR99021 in lung repair and regeneration during acute lung injury (ALI) remains unexplored. This study intends to elucidate the influence of CHIR99021 on AEC behaviour during the peak of the inflammatory phase of ALI and, after its attenuation, during the repair and regeneration stage. Furthermore, a long-term evaluation was conducted post CHIR99021 treatment at a late phase of the disease. Our results disclosed the role of GSK-3α/β inhibition in promoting AECI and AECII proliferation. Later administration of CHIR99021 during ALI progression contributed to the transdifferentiation of AECII into AECI and an AECI/AECII increase, suggesting its contribution to the renewal of the alveolar epithelial population and lung regeneration. This effect was confirmed to be maintained histologically in the long term. These findings underscore the potential of targeted therapies that modulate GSK-3α/β inhibition, offering innovative approaches for managing acute lung diseases, mostly in later stages where no treatment is available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alveolar Epithelial CellsAcute Lung InjuryPyridinesPyrimidinesAnimalsMiceLipopolysaccharidesGlycogen Synthase Kinase 3LungCell Proliferation

Stichwörter der Autor:innen

acute lung injuryalveolar epithelial cellscell proliferationglycogen synthase kinase-3lung regeneration

Substanzen

Chir 99021LipopolysaccharidesGlycogen Synthase Kinase 3PyridinesPyrimidines

Autor:innen und Institutionen

  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal.
  • ICVS/3B's-PT Government Associate Laboratory, 4806-909 Braga, Portugal.
  • Department of Internal Medicine, São João Universitary Hospital Center, 4200-319 Porto, Portugal.
  • Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.

ORCID-Profile: Catarina Barbosa-Matos, Ana Luísa Rodrigues Toste de Carvalho, Sandra Costa

Förderung

  • Fundação para a Ciência e Tecnologia
  • Programa Operacional Temático Factores de Competitividade
  • Programa Operacional Potencial Humano (POPH)
  • Programa Investigador Fundação para a Ciência e Tecnologia (FCT)
  • Programa Operacional Fatores de Competitividade (COMPETE)
  • national funds of FCT
  • ICVS Scientific Microscopy Platform, a member of the national infrastructure PPBI—Portuguese Platform of Bioimaging

Zitieren

APA

Fernandes, R., Barbosa-Matos, C., Borges-Pereira, C., Carvalho, A. L. R. T., & Costa, S. (2024). Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Alveolar Epithelial Cell Proliferation and Lung Regeneration in the Lipopolysaccharide-Induced Acute Lung Injury Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25021279

Vancouver

Fernandes R, Barbosa-Matos C, Borges-Pereira C, Carvalho ALRT, Costa S. Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Alveolar Epithelial Cell Proliferation and Lung Regeneration in the Lipopolysaccharide-Induced Acute Lung Injury Mouse Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021279

BibTeX
@article{Fernandes2024,
  author = {Fernandes, Raquel and Barbosa-Matos, Catarina and Borges-Pereira, Caroline and Carvalho, Ana Luísa Rodrigues Toste de and Costa, Sandra},
  title = {Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Alveolar Epithelial Cell Proliferation and Lung Regeneration in the Lipopolysaccharide-Induced Acute Lung Injury Mouse Model},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25021279}
}
Kostenlos starten →